Correlation Between C4 Therapeutics and Talaris Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Talaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Talaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Talaris Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Talaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Talaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Talaris Therapeutics.

Diversification Opportunities for C4 Therapeutics and Talaris Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between CCCC and Talaris is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Talaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talaris Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Talaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talaris Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Talaris Therapeutics go up and down completely randomly.

Pair Corralation between C4 Therapeutics and Talaris Therapeutics

If you would invest  298.00  in Talaris Therapeutics on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Talaris Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy1.56%
ValuesDaily Returns

C4 Therapeutics  vs.  Talaris Therapeutics

 Performance 
       Timeline  
C4 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Talaris Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Talaris Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Talaris Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

C4 Therapeutics and Talaris Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with C4 Therapeutics and Talaris Therapeutics

The main advantage of trading using opposite C4 Therapeutics and Talaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Talaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talaris Therapeutics will offset losses from the drop in Talaris Therapeutics' long position.
The idea behind C4 Therapeutics and Talaris Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine